Skip to content Search the desk⌘ Ctrl K Agent Sign in I ImageneBio, Inc.
I IMA ImageneBio, Inc.
I IMA ImageneBio, Inc.
Earnings When ImageneBio, Inc. reports, what it reported each quarter, and how the stock took the results.
27 quarters. Mar 31, 2020 to Sep 30, 2026. USD.
Next results · Q4 2026 Projected
Mar 9, after the close
Tue, Mar 9, 2027 in 107 days
Projected from its last 8 releases. The company has not named the day yet.
Quarter Q4 2026 · Ends about Dec 31, 2026
10-K window Mar 3 – 19 Quarter by quarter 3 years 5 years 10 years
Revenue Net income EPS Operating income Operating cash flow Free cash flow
Q4 2025 · derived $ 0 . 0 0 $0.00 No Q4 2024 on file
Revenue — —
Net income -$15.62M N/M
EPS -$0.91 N/M Q2 2026 Aug 5, 2026, before the openImageneBio, Inc. · CIK 1835579 · Engraved from SEC EDGAR
Revenue — —
Net income -$10.18M N/M
EPS -$0.63 N/M
Revenue — —
Net income -$10.62M N/M
EPS -$0.95 N/M
Revenue $0.00 —
Net income -$6.91M N/M
EPS — —
Results day Typical move ±4.5% A typical move of 4.5% either way
Up after 1 of 5, down after 4.
−2.1% +4.5% −5.6%
When it reports
Usual day Varies
After quarter end 36 to 43 days
10-Q filed 36 to 40 days over its last 8
10-K filed 65 to 76 days over its last 5 ended Sep 30, 2024 · filed Nov 7, 2024 · 38 d ended Dec 31, 2024 · filed Mar 6, 2025 · 65 d ended Mar 31, 2025 · filed May 8, 2025 · 38 d ended Jun 30, 2025 · filed Jul 24, 2025 · 24 d ended Sep 30, 2025 · filed Nov 12, 2025 · 43 d ended Dec 31, 2025 · filed Mar 10, 2026 · 69 d FY 2026 Q3 2026 Sep 30, 2026 Nov 9, 2026 · after-hours Nov 9, 2026 40 d 10-Q — — -$0.91 7.4% Q2 2026 Jun 30, 2026 Aug 5, 2026 · pre-market Aug 5, 2026 36 d 10-Q — — -$0.63 3.2% Q1 2026 Mar 31, 2026 May 7, 2026 · after-hours May 7, 2026 37 d 10-Q — — -$0.95 5.6%
FY 2025 Q4 2025 derived Dec 31, 2025 Mar 10, 2026 · pre-market Mar 10, 2026 69 d 10-K $0.00 — — +4.5% Q3 2025 Sep 30, 2025 Nov 12, 2025 · pre-market Nov 12, 2025 43 d 10-Q $0.00 −100.0% -$2.91 2.1% Q2 2025 Jun 30, 2025 — Jul 24, 2025 24 d 10-Q $0.00 — -$4.46 — Q1 2025 Mar 31, 2025 — May 8, 2025 38 d 10-Q $800.00K — -$3.80 —
FY 2024 Q4 2024 derived Dec 31, 2024 — Mar 6, 2025 65 d 10-K — — — — Q3 2024 Sep 30, 2024 — Nov 7, 2024 38 d 10-Q $3.50M +195.4% -$2.58 — Q2 2024 Jun 30, 2024 — Aug 8, 2024 39 d 10-Q — — -$0.28 — Q1 2024 Mar 31, 2024 — May 13, 2024 43 d 10-Q — — -$0.33 —
FY 2023 Q4 2023 derived Dec 31, 2023 Jan 18, 2024 · after-hours Mar 12, 2024 72 d 10-K $658.00K −87.9% — — Q3 2023 Sep 30, 2023 Nov 9, 2023 · pre-market Nov 9, 2023 40 d 10-Q $1.19M −81.5% -$0.40 — Q2 2023 Jun 30, 2023 — Aug 10, 2023 41 d 10-Q $2.00M +424.6% -$0.44 — Q1 2023 Mar 31, 2023 — May 15, 2023 45 d 10-Q $5.31M +57.0% -$0.39 —
FY 2022 Q4 2022 derived Dec 31, 2022 — Mar 14, 2023 73 d 10-K $5.45M −73.0% — — Q3 2022 Sep 30, 2022 — Nov 7, 2022 38 d 10-Q $6.40M +70.9% -$0.48 — Q2 2022 Jun 30, 2022 — Aug 11, 2022 42 d 10-Q $382.00K −89.2% -$0.57 — Q1 2022 Mar 31, 2022 — May 12, 2022 42 d 10-Q $3.38M −2.6% -$0.47 —
FY 2021 Q4 2021 derived Dec 31, 2021 — Mar 17, 2022 76 d 10-K $20.22M +31,001.5% — — Q3 2021 Sep 30, 2021 — Nov 10, 2021 41 d 10-Q $3.75M +32.4% -$0.40 — Q2 2021 Jun 30, 2021 Aug 12, 2021 · market hours Aug 12, 2021 43 d 10-Q $3.55M +15.5% -$0.35 — Q1 2021 Mar 31, 2021 May 13, 2021 · pre-market May 13, 2021 43 d 10-Q $3.47M +7.7% -$2.52 —
FY 2020 Q4 2020 derived Dec 31, 2020 — — — — $65.00K — — — Q3 2020 Sep 30, 2020 — — — — $2.83M — -$2.34 — Q2 2020 Jun 30, 2020 — — — — $3.07M — -$1.89 — Q1 2020 Mar 31, 2020 — — — — $3.23M — -$2.62 —
Earlier years, FY 2020 to FY 2023 The latest three years
Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
10-Q
May 7, 2026
The same quarter a year earlier, the figures the next ones will be compared with. Thaler holds no estimates.
Year over year, last four quarters
Revenue $0.00 Revenue, change from a year earlier: Q4 2025 n/m, Q3 2025 −100.0%, Q2 2025 n/m, Q1 2025 n/m n/m n/m −100.0% n/m
Net income -$6.91M Net income, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q4 2025 n/m n/m n/m n/m n/m
EPS — EPS, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q3 2025 n/m n/m n/m n/m n/m 7.4% by the close of Nov 10
Thaler Research Engraved from SEC EDGAR © 2026 Thaler. All rights reserved. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
3.2% by the close of Aug 7
ended Mar 31, 2026 · filed May 7, 2026 · 37 d ended Jun 30, 2026 · filed Aug 5, 2026 · 36 d ended Sep 30, 2026 · filed Nov 9, 2026 · 40 d window Mar 3 – 19 · projected The stock’s move from the last close before each release to the first close after it, over the last 5 releases. Largest: −7.4% after Q3 2026.
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Provenance Data status and checks